- Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer2023 | Publication without faculty affiliation
- A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer2020 | Faculty of Medicine in Pilsen
- Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer2021 | Faculty of Medicine in Pilsen
- Targeted therapy for differentiated and medullary thyroid cancer - how to treat and when to start?2019 | Publication without faculty affiliation
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Second Faculty of Medicine, Faculty of Science
- Implication of molecular genetic examination in a three generational family with multiple endocrine neoplasia type 2A2007 | Faculty of Medicine in Hradec Králové
- Implication of molecular genetic examination in a three generational family with multiple endocrine neoplasia type 2A2007 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Implication of molecular genetic examination in a three generational family with multiple endocrine neoplasia type 2A2007 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Implication of molecular genetic examination in a three generational family with multiple endocrine neoplasia type 2A2007 | First Faculty of Medicine
- Implication of molecular genetic examination in a Ihree generational family with multiple endoerine neoplasia type 2A2007 | First Faculty of Medicine, Second Faculty of Medicine
- Somatostatin receptor PET beyond the neuroendocrine tumors of the gastrointestinal tract - the review of literature2021 | First Faculty of Medicine
- Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation2019 | Second Faculty of Medicine, Faculty of Science
- Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b(5) Activity2020 | Faculty of Science
- Somatostatin receptor scintigraphy - 99mTc-EDDA/HYNIC-TOC - first clinical experience in the Czech Republic2012 | Second Faculty of Medicine